#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    B-cell lymphoma recurrent Sarcoma T-cell type acute leukaemia Bladder cancer Cerebral amyloid angiopathy Squamous cell carcinoma of the cervix Spinal cord injury Arginase deficiency Leiomyosarcoma recurrent Neonatal asphyxia Lymphangiosarcoma Bone marrow disorder Retinopathy proliferative Hypergammaglobulinaemia benign monoclonal Urea cycle disorder More trials…

    Learn about Rare Diseases

    Retinoblastoma – Basic Information Breast angiosarcoma – Treatment Usher’s syndrome – Diagnostics Crigler-Najjar syndrome – Basic Information Hepatic angiosarcoma Pleural mesothelioma malignant Kearns-Sayre syndrome – Trials in Disease Mantle cell lymphoma stage IV – Diagnostics Paroxysmal nocturnal haemoglobinuria – Basic Information Leukoencephalopathy More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Glofitamab Oxazepam Morphine Sulfate Corifollitropin Alfa Phleum Pratense Pollen Extract Patisiran Pirtobrutinib L-LEUCINE Xenon (129Xe) Vitamin A Bp Haloperidol Betamethasone Sodium Phosphate Cft1946 4-Hydroxy-N-Desmethyltamoxifen LTG-001 Metyrapone Bp Amlitelimab HLX43 Zanubrutinib Tivozanib More therapies…

    Learn about Your Condition

    Monkeypox Muscle strain Medullary thyroid cancer Uveal melanoma Hepatic angiosarcoma Endocarditis bacterial Renal cancer metastatic Oesophageal carcinoma Hepato-lenticular degeneration Wolfram syndrome Uterine leiomyosarcoma EGFR gene mutation Marginal zone lymphoma Uterine cancer Cardiac failure congestive More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Uncategorized

  • A Study of LAD191 Compared to Placebo and Adalimumab in Adults with Moderate-to-Severe Hidradenitis Suppurativa

    Recruiting

    2 1 1
    Investigated Diseases:
    • Hidradenitis
    Investigated Drugs:
    • Sodium Chloride
    • Adalimumab
    France Germany Ireland Italy Poland Spain

  • A study of saruparib with radiotherapy and hormone therapy for men with high-risk prostate cancer who have a BRCA gene mutation

    Recruiting

    3 1 1
    Investigated Diseases:
    • Prostate cancer
    Investigated Drugs:
    • Abiraterone Acetate
    • Saruparib
    Austria Belgium Finland France Germany Hungary +5

  • A study testing direclidine compared to placebo in adults with schizophrenia who need hospital care

    Recruiting

    3 1
    Investigated Diseases:
    • Schizophrenia
    Bulgaria Hungary Romania

  • Testing dapagliflozin to slow kidney function decline in patients with autosomal dominant polycystic kidney disease

    Recruiting

    3 1 1
    Investigated Drugs:
    • Dapagliflozin
    Austria Germany The Netherlands Spain

  • A study testing venetoclax for treating acute graft-versus-host disease in patients who received a stem cell transplant from a donor

    Recruiting

    2 1 1 1
    Investigated Drugs:
    • Venetoclax
    Austria

  • Study of xaluritamig plus abiraterone for men with metastatic castration-resistant prostate cancer who have not received chemotherapy

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Prostate cancer
    Investigated Drugs:
    • Cabazitaxel
    • Siltuximab
    • Xaluritamig
    Austria Belgium France Germany Greece Italy +3
Previous Page
1 … 105 106 107 108 109 … 1,646
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!